$RNAC
Cartesian Therapeutics, Inc.

2019 Q3 Form 10-Q Financial Statement

#000145368719000104 Filed on August 08, 2019

View on sec.gov

Income Statement

Concept 2019 Q3 2019 Q2 2018 Q2
Revenue $0.00 $13.00K $0.00
YoY Change -100.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $3.690M $4.110M $4.360M
YoY Change -9.11% -5.73% -11.02%
% of Gross Profit
Research & Development $8.104M $12.13M $14.41M
YoY Change -31.81% -15.78% 31.04%
% of Gross Profit
Depreciation & Amortization $200.0K $200.0K $400.0K
YoY Change 0.0% -50.0% 100.0%
% of Gross Profit
Operating Expenses $11.79M $16.25M $18.77M
YoY Change -26.01% -13.43% 18.07%
Operating Profit -$11.79M -$16.24M -$18.77M
YoY Change -26.01% -13.5% 18.26%
Interest Expense $388.0K $400.0K $365.0K
YoY Change 1.04% 9.59% 30.82%
% of Operating Profit
Other Income/Expense, Net -$3.000K $5.000K $8.000K
YoY Change -200.0% -37.5%
Pretax Income -$11.99M -$16.39M -$18.80M
YoY Change -25.06% -12.82% 17.72%
Income Tax
% Of Pretax Income
Net Earnings -$11.99M -$16.39M -$18.80M
YoY Change -25.04% -12.78% 17.72%
Net Earnings / Revenue -126107.69%
Basic Earnings Per Share
Diluted Earnings Per Share -$258.3K -$365.4K -$840.8K
COMMON SHARES
Basic Shares Outstanding 44.96M shares 44.79M shares 22.35M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q3 2019 Q2 2018 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $34.20M $41.70M $66.20M
YoY Change -32.28% -37.01% -41.26%
Cash & Equivalents $34.23M $30.20M $60.24M
Short-Term Investments $11.50M $6.000M
Other Short-Term Assets $1.900M $2.800M $2.600M
YoY Change -62.75% 7.69% 36.84%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $36.12M $44.45M $68.84M
YoY Change -35.0% -35.43% -39.92%
LONG-TERM ASSETS
Property, Plant & Equipment $1.452M $1.620M $2.137M
YoY Change -31.15% -24.19% 0.28%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.400M $0.00 $2.500M
YoY Change -46.15% -100.0%
Total Long-Term Assets $3.425M $2.498M $4.602M
YoY Change -27.97% -45.72% 88.07%
TOTAL ASSETS
Total Short-Term Assets $36.12M $44.45M $68.84M
Total Long-Term Assets $3.425M $2.498M $4.602M
Total Assets $39.54M $46.95M $73.44M
YoY Change -34.45% -36.07% -37.25%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.478M $2.463M $1.789M
YoY Change 18.05% 37.67% -58.2%
Accrued Expenses $5.316M $5.789M $10.18M
YoY Change -47.97% -43.16% 18.49%
Deferred Revenue $1.023M $1.023M $1.918M
YoY Change -45.09% -46.66%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $20.90M $21.50M
YoY Change -1.88%
Total Short-Term Liabilities $29.48M $31.91M $13.89M
YoY Change -14.88% 129.7% -30.73%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $21.20M
YoY Change -100.0% 271.93%
Other Long-Term Liabilities $0.00 $0.00 $1.104M
YoY Change -100.0% -100.0% -11.68%
Total Long-Term Liabilities $0.00 $0.00 $1.104M
YoY Change -100.0% -100.0% -11.68%
TOTAL LIABILITIES
Total Short-Term Liabilities $29.48M $31.91M $13.89M
Total Long-Term Liabilities $0.00 $0.00 $1.104M
Total Liabilities $44.46M $46.89M $49.18M
YoY Change -11.65% -4.64% 26.6%
SHAREHOLDERS EQUITY
Retained Earnings -$320.9M -$308.9M -$247.2M
YoY Change 21.92% 24.96% 35.32%
Common Stock $5.000K $5.000K $3.000K
YoY Change 66.67% 66.67% 200.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$4.915M $56.00K $21.66M
YoY Change
Total Liabilities & Shareholders Equity $39.54M $46.95M $73.44M
YoY Change -34.45% -36.07% -37.25%

Cashflow Statement

Concept 2019 Q3 2019 Q2 2018 Q2
OPERATING ACTIVITIES
Net Income -$11.99M -$16.39M -$18.80M
YoY Change -25.04% -12.78% 17.72%
Depreciation, Depletion And Amortization $200.0K $200.0K $400.0K
YoY Change 0.0% -50.0% 100.0%
Cash From Operating Activities -$11.12M -$7.200M -$16.97M
YoY Change -30.63% -57.57% 97.1%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$10.00K -$270.0K
YoY Change -100.0% -96.3% -32.5%
Acquisitions
YoY Change
Other Investing Activities $11.52M $4.850M $18.95M
YoY Change 89.79% -74.41% 70.87%
Cash From Investing Activities $11.51M $4.850M $18.68M
YoY Change 91.2% -74.04% 74.58%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 5.030M 370.0K 310.0K
YoY Change 1834.62% 19.35% -99.43%
NET CHANGE
Cash From Operating Activities -11.12M -7.200M -16.97M
Cash From Investing Activities 11.51M 4.850M 18.68M
Cash From Financing Activities 5.030M 370.0K 310.0K
Net Change In Cash 5.420M -1.980M 2.020M
YoY Change -155.59% -198.02% -96.39%
FREE CASH FLOW
Cash From Operating Activities -$11.12M -$7.200M -$16.97M
Capital Expenditures $0.00 -$10.00K -$270.0K
Free Cash Flow -$11.12M -$7.190M -$16.70M
YoY Change -30.37% -56.95% 103.41%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
dei Entity Central Index Key
EntityCentralIndexKey
0001453687
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2019Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2019Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
22471776 shares
CY2019Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
44952951 shares
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
22471776 shares
CY2019Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
44952951 shares
CY2018Q2 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
100000 USD
us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
100000 USD
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 USD
CY2019Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
344100 USD
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2019Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2019Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2019Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2019-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-37798
dei Entity Registrant Name
EntityRegistrantName
Selecta Biosciences, Inc
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-1622110
dei Entity Address Address Line1
EntityAddressAddressLine1
480 Arsenal Way
dei Entity Address City Or Town
EntityAddressCityOrTown
Watertown
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02472
dei City Area Code
CityAreaCode
617
dei Local Phone Number
LocalPhoneNumber
923-1400
dei Security12b Title
Security12bTitle
Common Stock, $0.0001 par value per share
dei Trading Symbol
TradingSymbol
SELB
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
true
dei Entity Shell Company
EntityShellCompany
false
CY2019Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
44962951 shares
CY2019Q2 selb Cash Cash Equivalents Restricted Cashand Restricted Cash Equivalents Current
CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsCurrent
30479000 USD
CY2018Q4 selb Cash Cash Equivalents Restricted Cashand Restricted Cash Equivalents Current
CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsCurrent
37403000 USD
CY2019Q2 us-gaap Short Term Investments
ShortTermInvestments
11480000 USD
CY2018Q4 us-gaap Short Term Investments
ShortTermInvestments
0 USD
CY2019Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2490000 USD
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4673000 USD
CY2019Q2 us-gaap Assets Current
AssetsCurrent
44449000 USD
CY2018Q4 us-gaap Assets Current
AssetsCurrent
42076000 USD
CY2019Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1620000 USD
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2127000 USD
CY2019Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
878000 USD
CY2019Q2 us-gaap Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
0 USD
CY2018Q4 us-gaap Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
279000 USD
CY2019Q2 us-gaap Assets
Assets
46947000 USD
CY2018Q4 us-gaap Assets
Assets
44482000 USD
CY2019Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
2463000 USD
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1100000 USD
CY2019Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5789000 USD
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
11700000 USD
CY2019Q2 us-gaap Loans Payable Current
LoansPayableCurrent
21548000 USD
CY2018Q4 us-gaap Loans Payable Current
LoansPayableCurrent
21385000 USD
CY2019Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9036000 USD
CY2019Q2 us-gaap Operating Expenses
OperatingExpenses
16248000 USD
CY2019Q2 us-gaap Common Stock Value
CommonStockValue
5000 USD
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
3000 USD
CY2019Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1085000 USD
CY2019Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1023000 USD
CY2018Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
959000 USD
CY2019Q2 us-gaap Liabilities Current
LiabilitiesCurrent
31908000 USD
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
35144000 USD
CY2018Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
34000 USD
CY2019Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
14983000 USD
CY2018Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
13818000 USD
CY2019Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
0 USD
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
904000 USD
CY2019Q2 us-gaap Liabilities
Liabilities
46891000 USD
CY2018Q4 us-gaap Liabilities
Liabilities
49900000 USD
CY2019Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
313447000 USD
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
279539000 USD
CY2019Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-308871000 USD
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-280403000 USD
CY2019Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4525000 USD
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4557000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
56000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-5418000 USD
CY2019Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
46947000 USD
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
44482000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13000 USD
CY2018Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
23000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0 USD
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12134000 USD
CY2018Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14407000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
19487000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
25546000 USD
CY2019Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4114000 USD
CY2018Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4362000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8627000 USD
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-16235000 USD
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-18769000 USD
CY2018Q2 us-gaap Operating Expenses
OperatingExpenses
18769000 USD
us-gaap Operating Expenses
OperatingExpenses
28114000 USD
us-gaap Operating Expenses
OperatingExpenses
34582000 USD
us-gaap Investment Income Net
InvestmentIncomeNet
523000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-64000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-28091000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-34582000 USD
CY2019Q2 us-gaap Investment Income Net
InvestmentIncomeNet
246000 USD
CY2018Q2 us-gaap Investment Income Net
InvestmentIncomeNet
246000 USD
us-gaap Investment Income Net
InvestmentIncomeNet
534000 USD
CY2019Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-10000 USD
CY2018Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
84000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-40000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
71000 USD
CY2019Q2 us-gaap Interest Expense
InterestExpense
400000 USD
CY2018Q2 us-gaap Interest Expense
InterestExpense
365000 USD
us-gaap Interest Expense
InterestExpense
796000 USD
us-gaap Interest Expense
InterestExpense
715000 USD
CY2019Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5000 USD
CY2018Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
8000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
8000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-16394000 USD
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-18796000 USD
us-gaap Net Income Loss
NetIncomeLoss
-28468000 USD
us-gaap Net Income Loss
NetIncomeLoss
-34684000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
7000 USD
CY2018Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-90000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
29000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-71000 USD
CY2019Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1000 USD
CY2018Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
12000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
3000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
15000 USD
CY2019Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-16386000 USD
CY2018Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-18874000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-28436000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-34740000 USD
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.37
CY2018Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.84
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.68
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.55
CY2019Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
44855083 shares
CY2018Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
22355603 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
41668902 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
22350591 shares
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-5418000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
20000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
145000 USD
CY2019Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
30942000 USD
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1180000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
22000 USD
CY2019Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
2000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-12074000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
14819000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
372000 USD
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1251000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
7000 USD
CY2019Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-16394000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
56000 USD
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
51814000 USD
CY2018Q1 us-gaap Cumulative Effect Of New Accounting Principle In Period Of Adoption
CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
1830000 USD
CY2018Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
51000 USD
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1153000 USD
CY2018Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
19000 USD
CY2018Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
3000 USD
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-15888000 USD
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
38982000 USD
CY2018Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
311000 USD
CY2018Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1245000 USD
CY2018Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-90000 USD
CY2018Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
12000 USD
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-18796000 USD
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
21664000 USD
us-gaap Net Income Loss
NetIncomeLoss
-28468000 USD
us-gaap Net Income Loss
NetIncomeLoss
-34684000 USD
us-gaap Depreciation
Depreciation
355000 USD
us-gaap Depreciation
Depreciation
584000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
131000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
91000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
22000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
2431000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
2439000 USD
us-gaap Paid In Kind Interest
PaidInKindInterest
267000 USD
us-gaap Paid In Kind Interest
PaidInKindInterest
265000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
155000 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-76000 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2912000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
107000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1363000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-11000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-88000 USD
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-6231000 USD
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
1167000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-27437000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-30382000 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
4850000 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
33955000 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
18188000 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
13900000 USD
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
1992000 USD
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
0 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
456000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
77000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
31000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-11274000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
19630000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
30942000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
145000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
311000 USD
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
20000 USD
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
51000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
31479000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
362000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
29000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-71000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-7203000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-10461000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
37682000 USD
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
71027000 USD
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
30479000 USD
CY2018Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
60566000 USD
us-gaap Interest Paid Net
InterestPaidNet
634000 USD
us-gaap Interest Paid Net
InterestPaidNet
539000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
0 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
183000 USD
selb Equity Offering Costs In Accrued Liabilities
EquityOfferingCostsInAccruedLiabilities
14000 USD
selb Equity Offering Costs In Accrued Liabilities
EquityOfferingCostsInAccruedLiabilities
0 USD
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
3000 USD
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
15000 USD
CY2019Q2 us-gaap Short Term Investments
ShortTermInvestments
11500000 USD
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
30500000 USD
CY2019Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-308900000 USD
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-280400000 USD
CY2019Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
3000 USD
CY2019Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
0 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.55
CY2019Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
11480000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Use of Estimates</span><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company’s management considers many factors in selecting appropriate financial accounting policies and controls, and bases its estimates on historical experience and other market-specific or other relevant assumptions that it believes to be reasonable under the circumstances. In preparing these consolidated financial statements, management used significant estimates in the following areas, among others: revenue recognition, accounting for stock-based compensation and estimating accrued research and development expenses. The Company assesses the above estimates on an ongoing basis; however, actual results could materially differ from those estimates.</span></div>
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
0 USD
CY2018Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
60237000 USD
CY2019Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
279000 USD
CY2018Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
0 USD
CY2019Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
0 USD
CY2018Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
329000 USD
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
30479000 USD
CY2018Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
60566000 USD
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
30200000 USD
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Concentrations of Credit Risk and Off‑Balance Sheet Risk</span></div>Financial instruments that potentially subject the Company to concentration of credit risk consist primarily of cash, cash equivalents, short-term deposits and investments, and accounts receivable. Cash and cash equivalents are deposited with federally insured financial institutions in the United States and may, at times, exceed federally insured limits. Management believes that the financial institutions that hold the Company’s deposits are financially credit worthy and, accordingly, minimal risk exists with respect to those balances. Generally, these deposits may be redeemed upon demand and therefore bear minimal interest rate risk. As an integral part of operating its Russian subsidiary, the Company also maintains cash in Russian bank accounts in denominations of both Russian rubles and U.S. dollars.
CY2019Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
37000 USD
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 USD
CY2018Q4 selb Accrued Research And Development Costs Current
AccruedResearchAndDevelopmentCostsCurrent
5344000 USD
CY2019Q2 selb Accrued Audit Fees Current
AccruedAuditFeesCurrent
941000 USD
CY2019Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
1085000 USD
CY2019Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1085000 USD
CY2019Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
11477000 USD
CY2019Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
11480000 USD
CY2019Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
11477000 USD
CY2018Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
0 USD
CY2018Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
0 USD
CY2019Q2 selb Availablefor Sale Debt Securities Number Of Positions
AvailableforSaleDebtSecuritiesNumberOfPositions
10 position
CY2019Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
0 position
CY2019Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 USD
CY2019Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
1085000 USD
CY2018Q4 selb Accrued Audit Fees Current
AccruedAuditFeesCurrent
994000 USD
us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
30900000 USD
CY2016Q3 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
64500000 USD
CY2019Q2 selb Accrued Grant Refund Current
AccruedGrantRefundCurrent
0 USD
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
22350591 shares
CY2018Q4 selb Accrued Grant Refund Current
AccruedGrantRefundCurrent
175000 USD
CY2019Q2 us-gaap Interest Payable Current
InterestPayableCurrent
105000 USD
CY2018Q4 us-gaap Interest Payable Current
InterestPayableCurrent
106000 USD
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.37
CY2019Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
338000 USD
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6679000 USD
CY2018Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.84
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.68
CY2018Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
509000 USD
CY2019Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4424000 USD
CY2019Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-16394000 USD
CY2018Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-18796000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-28468000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-34684000 USD
CY2019Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
44855083 shares
CY2018Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
22355603 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
41668902 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5008082 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3459102 shares
CY2016Q2 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
10126118 shares
us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
44952951 shares
CY2019Q2 selb Votes Per Shareof Common Stock
VotesPerShareofCommonStock
1 vote
CY2019Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5789000 USD
us-gaap Dividends Common Stock
DividendsCommonStock
0 USD
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
11700000 USD
CY2019Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6044000 USD
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4552000 USD
CY2019Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1620000 USD
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2127000 USD
CY2019Q2 us-gaap Depreciation
Depreciation
200000 USD
CY2018Q2 us-gaap Depreciation
Depreciation
400000 USD
us-gaap Depreciation
Depreciation
400000 USD
us-gaap Depreciation
Depreciation
600000 USD
CY2019Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1705000 USD
CY2018Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2497000 USD
CY2019Q2 selb Accrued Rent And Lease Incentive Payable Current
AccruedRentAndLeaseIncentivePayableCurrent
0 USD
CY2018Q4 selb Accrued Rent And Lease Incentive Payable Current
AccruedRentAndLeaseIncentivePayableCurrent
117000 USD
CY2019Q2 selb Accrued Collaborationand Licensing
AccruedCollaborationandLicensing
319000 USD
CY2018Q4 selb Accrued Collaborationand Licensing
AccruedCollaborationandLicensing
1222000 USD
CY2019Q2 selb Accrued Patent Fees Current
AccruedPatentFeesCurrent
565000 USD
CY2018Q4 selb Accrued Patent Fees Current
AccruedPatentFeesCurrent
736000 USD
CY2019Q1 selb Operating Lease Remaining Lease Term
OperatingLeaseRemainingLeaseTerm
P15M
CY2019Q2 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
600000 USD
CY2018Q2 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
500000 USD
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1100000 USD
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1000000.0 USD
CY2019Q2 selb Accrued Research And Development Costs Current
AccruedResearchAndDevelopmentCostsCurrent
1816000 USD
CY2019Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
341000 USD
CY2019Q1 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.100
CY2017Q4 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
5100 sqft
us-gaap Operating Lease Cost
OperatingLeaseCost
682000 USD
CY2019Q2 us-gaap Variable Lease Cost
VariableLeaseCost
211000 USD
us-gaap Variable Lease Cost
VariableLeaseCost
414000 USD
CY2019Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
3000 USD
us-gaap Short Term Lease Cost
ShortTermLeaseCost
11000 USD
CY2019Q2 us-gaap Lease Cost
LeaseCost
555000 USD
us-gaap Lease Cost
LeaseCost
1107000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
747000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
375000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1122000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
735000 USD
CY2019Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P0M24D
CY2019Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.10
selb Debt Instrument Event Of Default Minimum Assets Trigger
DebtInstrumentEventOfDefaultMinimumAssetsTrigger
300000 USD
selb Debt Instrument Event Of Default Minimum Amount In Excess Of Indebtedness Trigger
DebtInstrumentEventOfDefaultMinimumAmountInExcessOfIndebtednessTrigger
300000 USD
CY2019Q1 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
1.50
CY2019Q1 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
1.50
CY2019Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
8947568 shares
CY2018Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
5951523 shares
CY2019Q1 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
1.50
CY2019Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1251000 USD
CY2018Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1286000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2431000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2439000 USD
CY2016Q4 selb License And Option Agreement Number Of Additional Targets For Which Other Party May Exercise Options For Additional Licenses
LicenseAndOptionAgreementNumberOfAdditionalTargetsForWhichOtherPartyMayExerciseOptionsForAdditionalLicenses
4 target
CY2019Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
9300000 USD
CY2019Q2 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.088
CY2019Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2018Q4 selb Contractwith Customer Liability Deferred Revenue
ContractwithCustomerLiabilityDeferredRevenue
14777000 USD
selb Contractwith Customer Liability Deferred Revenue Increase From Cash Receipts
ContractwithCustomerLiabilityDeferredRevenueIncreaseFromCashReceipts
1252000 USD
selb Contractwith Customer Liability Deferred Revenue Revenue Recognized
ContractwithCustomerLiabilityDeferredRevenueRevenueRecognized
23000 USD
CY2019Q2 selb Contractwith Customer Liability Deferred Revenue
ContractwithCustomerLiabilityDeferredRevenue
16006000 USD
CY2018Q4 selb Contractwith Customer Liability Other
ContractwithCustomerLiabilityOther
2126000 USD
selb Contractwith Customer Liability Other Increase From Cash Receipts
ContractwithCustomerLiabilityOtherIncreaseFromCashReceipts
0 USD
selb Contractwith Customer Liability Other Revenue Recognized
ContractwithCustomerLiabilityOtherRevenueRecognized
1807000 USD
CY2019Q2 selb Contractwith Customer Liability Other
ContractwithCustomerLiabilityOther
319000 USD
CY2018Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
16903000 USD
selb Contractwith Customer Liability Increase From Cash Receipts
ContractwithCustomerLiabilityIncreaseFromCashReceipts
1252000 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1830000 USD
CY2019Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
16325000 USD
CY2019Q2 selb Contractwith Customer Liability Other Current
ContractwithCustomerLiabilityOtherCurrent
300000 USD
CY2019Q1 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
22188706 shares
CY2019Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
selb Defined Contribution Plan Employers Matching Contribution Vesting Period
DefinedContributionPlanEmployersMatchingContributionVestingPeriod
P4Y
CY2019Q2 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
100000 USD
us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
100000 USD

Files In Submission

Name View Source Status
0001453687-19-000104-index-headers.html Edgar Link pending
0001453687-19-000104-index.html Edgar Link pending
0001453687-19-000104.txt Edgar Link pending
0001453687-19-000104-xbrl.zip Edgar Link pending
aschecteremploymentagr.htm Edgar Link pending
exhibit31106302019.htm Edgar Link pending
exhibit31206302019.htm Edgar Link pending
exhibit32106302019.htm Edgar Link pending
exhibit32206302019.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
selb-20190630.xsd Edgar Link pending
selb-20190630_cal.xml Edgar Link unprocessable
selb-20190630_def.xml Edgar Link unprocessable
selb-20190630_lab.xml Edgar Link unprocessable
selb-20190630_pre.xml Edgar Link unprocessable
selectabiosciences10-q.htm Edgar Link pending
selectabiosciences10-q_htm.xml Edgar Link completed
Show.js Edgar Link pending